应《网络安全法》要求，自2017年10月1日起，未进行实名认证将不得使用互联网跟帖服务。为保障您的帐号能够正常使用，请尽快对帐号进行手机号验证，感谢您的理解与支持！

24小时热门版块排行榜    

CyRhmU.jpeg
小木虫论坛-学术科研互动平台 » 学术交流区 » 论文投稿 » 投稿求助 » 有知道Biomolecules & Therapeutics的格式要求的不?
71/1返回列表
查看: 1445  |  回复: 6
只看楼主@他人 存档 新回复提醒 (忽略) 收藏    在APP中查看

小油2716

木虫 (正式写手)

[求助] 有知道Biomolecules & Therapeutics的格式要求的不?

老师很忙,没空管我,就告诉我投Biomolecules & Therapeutics这个杂志.想找投稿的格式要求的,突然发现自己很菜,找不到只能请有经验的童鞋帮忙啦
回复此楼

» 猜你喜欢

» 本主题相关价值贴推荐，对您同样有帮助:
实验小疯子~
1楼2011-07-19 14:38:10
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hailiang1029

金虫 (正式写手)
2楼2011-07-19 14:57:57
 已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hailiang1029

金虫 (正式写手)
杂志主页：http://biomolther.org/for/authors.html
样文章：http://pdf.medrang.co.kr/BT/2011/019/BT019-02-17.pdf
赞一下 回复此楼
3楼2011-07-19 15:02:09
 已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hailiang1029

金虫 (正式写手)
杂志主页就有对文章的详细要求~
赞一下 回复此楼
4楼2011-07-19 15:03:42
 已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hailiang1029

金虫 (正式写手)

【答案】应助回帖

小油2716(金币+50): 谢谢啊,我自己看一下~ 2011-07-19 15:07:59
Organization of the Manuscript

The manuscript must be type written using only Times New Roman font 12 and double-spaced throughout, including references, tables, and figure legends, with at least on 1-inch margins. Manuscripts should contain the following sections, and all pages should be numbered consecutively.

1. Title Page
This should contain an article title of less than 150 characters, the authors' names and complete affiliations, and the name and address for manuscript correspondence (including email address and fax number). Note that the title should not contain any nonstandard abbreviations. The corresponding author must confirm that the correspondence address in the manuscript coincides with the address in the cover letter.

2. Running Title
A running title, which conveys the sense of the full title, should not exceed 60 characters, including spaces and punctuation. Common abbreviations may be used.

3. Abstract
The abstract should succinctly and clearly present the major findings reported in the manuscript. It must not exceed 250 words nor contain abbreviations or specialized terms. After the abstract, a list of up to 6 keywords should be included that will be useful for indexing or searching.

4. Introduction
This section should present the purpose of the reported studies and their relationship to earlier work in the field. It should not be an extensive review of the literature nor, in general, exceed two typed pages.

5. Materials and Methods
This section should contain explicit, concise descriptions of all new methods or procedures employed. Whereas modifications of previously published methods must be described, commonly used procedures require only a citation of the original source. Descriptions of methods must be sufficiently complete to permit a qualified reader to repeat the reported experiments. The name and location (city, state, and country) of commercial suppliers of chemicals, reagents, and equipment must be given.

6. Results
This section contains experimental data, but with no discussion of their signifi cance. Results are typically presented in figures and tables, with no duplication of information in the text. Magnitudes of reported variables should be expressed in numerals. Generally, units are abbreviated without punctuation, and with no distinction between singular and plural forms (e.g., 1 mg, 25 mg). Sufficient data should be presented to allow for judgment concerning the variability and reliability of the results. Statistical probability (p) in tables, figures, and figure legends should be expressed as *p
7. Discussion
This section should focus on interpretation of the results, rather than be a repetition of the Results section. It must be as concise as possible and should not exceed four typed pages.

8. Acknowledgments
The acknowledgments section should be brief and should precede the references. Personal assistance and financial support are noted here.

9. References
References are cited in the text by giving the first author's name (or the fi rst and second if they are the only authors) and the year of publication (e.g. Kim, 1999; Hayaishi and Ueda, 1982; or Ayrton et al., 1991). In the reference list, the references should be arranged alphabetically by author and not numbered. The names of all authors should be given in the reference list. If reference is made to more than one publication by the same author(s) in the same year, suffixes (a, b, c, etc.) should be added to the year in the text citation and in the references list. Abbreviations for journals should conform to the most recent edition of the Chemical Abstracts Service Source Index. The total number of references is limited to 40 except review articles. References to personal communications, unpublished observations, and papers submitted for publication are given in parentheses at the appropriate location in the text, not in the list of references. Only papers that have been officially accepted for publication may be cited as "in press" in the reference list. The authors are responsible for the accuracy of references. The formats for journal articles, chapters, and book references are as follows:

Journal article:
Ayrton, A. D., Ioannides, C. and Canter, H. V. (1991) Induction of the cytochrome p450 I and IV families and peroxisomal proliferation in the liver of rats treated with benoxaprofen. Biochem. Pharmacol. 42, 109-115.


Book reference:
Hayaishi, O. and Ueda, K. (1982) ADP-ribosylation reactions, Biology and Medicine. Academic Press., New York.


Book chapter:
Price, D. and Williams-Ashman, H. G. (1961) The accessory reproductive glands of mammals. In Sex and Internal Secretions (W. C. Young, Ed.), pp. 366-448. Williams & Wilkins, Baltimore.  

10. Footnotes
Footnotes should be listed on a separate page and used to provide thesis information and citation of meeting abstracts where the work was previously presented, etc.

11. Tables
Tables should have titles and sufficient experimental detail in a legend immediately following the title to be understandable without reference to the text. Each column in a table must have a heading, and abbreviations, when necessary, should be defined in the legend.

12. Figures
Figures should have titles and explanatory legends containing sufficient details for interpretation. All legends should be printed consecutively in a separate section of the manuscript. All letters in fi gures must be written in the Arial font and be uniform in size and style within each figure. The size of all figures must be prepared the same as appeared in the ultimately published paper (as 1, 1.5, or 2 column-width 87 mm, 120 mm, 178 mm, respectively). Figures should be consecutively numbered using Arabic numerals. Artwork that is supplied electronically must be prepared in high resolution and sent to the Publishing office after acceptance; 1,200 dpi bitmap mode for black and white images such as line graphs, 600 dpi grayscale mode for images such as gels or blots , and 600 dpi CMYK mode for color images. EPS or TIFF fi les are recommended. Powerpoint files are acceptable only when the resolution of images meets the publication quality requirements. Color figures (saved as CMYK files) should be submitted only if reproduction in color is intended. A scale bar should be supplied with photomicrographs. Symbols and abbreviations must be defined in the figure legends. If figure editing is required by the editorial staff for publication in Biomolecules & Therapeutics, charges for figure artwork may be issued to the corresponding authors.

13. Supplemental Data
Supplemental data are peer-reviewed materials directly relevant to the conclusion of an article that cannot be included in the printed version. Supplemental data are not subedited, so authors should ensure that it is supplied ready for publication online. Accepted supplemental file formats are Microsoft Office files, movie files (.mov/.mpg), and Acrobat files (.pdf ).

14. Check List (on the Web)
If your study is related to a crude extract, you will be asked to submit additional documents by the Editorial office. The required documents may include intellectual property status (patented or patent applied) and/or chemical specification data, such as HPLC or GC chemical profile data, for crude extracts.


Ethics

The cover letter must state that manuscripts contain original materials, not published and not being considered for publication elsewhere by another journal in whole or in part in any language, including publicly accessible web sites, except as an abstract. Studies involving human subjects and/or parts of human tissues should be performed in accordance with the ethical standards set by the Helsinki Declaration of the World Medical Association in 1964, and revised in 2004. The authors also must certify that animal experiments were conducted in accordance with the guidelines for the Care and Use of Laboratory Animals approved by the authors' institutional review board or responsible governmental administrations. General instructions in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (www. icmje.org)' can be applied for the research and publication ethics issues not covered by Biomolecules & Therapeutics


Conflict of Interest

When a corresponding author submits a manuscript to Biomolecules & Therapeutics, she or he is responsible for disclosing all financial relationships of authors (such as employment, honoraria, consultancies, stock ownership, stock option, etc.) in the manuscript which may bias the work in the manuscript. The corresponding author must complete a Conflict of Interest Disclosure Form on behalf of all authors and submit the form to the editorial office. If a potential conflict of interest is declared, a notification concerning the relationship will be published. The research or project funding/support should be declared in the 'Acknowledgment' section of the manuscript.


Editorial Review

All manuscripts are subjected to editorial peer review. Upon submission, each manuscript will be quality checked by the editorial office before being sent for review, usually by an Editor and two more referees. The referee's comments and Editor's recommendation will be reviewed by the Editor-in Chief, who will communicate the decision to the author. A paper may be accepted in its original form or accepted subject to revision. The reviewers' suggestions will be conveyed to the corresponding author without identifying the designated editor and reviewers and the author will have an opportunity for revision. If a manuscript returned to an author for revision is held longer than two months, or if revision is sufficiently extensive, the date of receipt of the revised manuscript will be substituted for the initial date of receipt.
赞一下 回复此楼
5楼2011-07-19 15:04:56
 已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

joyfulnoise

荣誉版主 (知名作家)

懒人一枚~

优秀版主优秀版主
楼上的ID很熟悉
哈哈哈
赞一下 回复此楼

» 本帖已获得的红花（最新10朵）

hailiang1029
6楼2011-07-19 17:29:52
 已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hailiang1029

金虫 (正式写手)
送鲜花一朵
引用回帖:
Originally posted by joyfulnoise at 2011-07-19 17:29:52:
楼上的ID很熟悉
哈哈哈

7楼2011-07-19 18:56:04
 已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 小油2716 的主题更新
71/1返回列表
普通表情 龙 兔 虎 猫
信息提示
关闭
请填处理意见
关闭